Table II.
N (%) | Overall (N=203) | Age group
|
|
---|---|---|---|
Paediatric (N=107) | Adult (N=96) | ||
Gender (male) | 102 (50%) | 58 (54%) | 44 (46%) |
Race (black) | 198 (98%) | 103 (96%) | 95 (99%) |
Range of maximum sPLA2 value | |||
>0 – 25 | 106 (52%) | 43 (40%) | 63 (66%) |
>25 – 50 | 34 (17%) | 18 (17%) | 16 (17%) |
>50 – 100 | 22 (11%) | 16 (15%) | 6 (6%) |
>100 – 200 | 13 (6%) | 9 (8%) | 4 (4%) |
>200 – 800 | 28 (14%) | 21 (20%) | 7 (7%) |
Acute Chest Syndrome | 22 (11%) | 11 (10%) | 11 (11%) |
sPLA2, secretory phospholipase A2